Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624662 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device
A Phase 3 study of Bilateral Nasal Polyposis, sponsored by Optinose US.
- Completed
- Registry status
- Phase 3
- Development phase
- 323
- Enrollment target
- 10
- Study locations
NCT01624662 is a Phase 3 study of Bilateral Nasal Polyposis that has completed, run by Optinose US. The registered enrollment target is 323 participants. The trial reports 10 study locations across 9 states.
The verdict
NCT01624662, a Phase 3 study of Bilateral Nasal Polyposis, has completed, sponsored by Optinose US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 323 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this study was to compare the efficacy of intranasal administration of 100, 200, and 400 μg twice daily (bid) of fluticasone propionate, delivered by the Optinose device, with matching placebo in subjects with bilateral nasal polyposis and nasal congestion.
Conditions Studied
Interventions
- DRUG Fluticasone propionate
Study Locations (10)
Oregon
- Allergy and Asthma Research Group - Eugene
- Baker Allergy, Asthma and Dermatology Research Center, LLC - Lake Oswego
California
- Bensch Clinical Research LLC - Stockton
Colorado
- Colorado Allergy & Asthma Centers, PC - Centennial
Kentucky
- Advanced ENT and Allergy - Louisville
Maryland
- Institute for Asthma and Allergy - Wheaton
New Jersey
- Atlantic Research Center, LLC - Ocean City
Pennsylvania
- Valley Clinical Research Center - Bethlehem
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2013-10-30 |
| Est. Completion | 2015-07-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01624662
The ClinicalTrials.gov registry entry for NCT01624662 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optinose US, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bilateral Nasal Polyposis appearing as the primary indexed condition, and to 1 intervention - of which Fluticasone propionate is the first listed.
NCT01624662 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Oregon, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT01624662 about?
NCT01624662 is a clinical study titled "Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device". The primary objective of this study was to compare the efficacy of intranasal administration of 100, 200, and 400 μg twice daily (bid) of fluticasone propionate, delivered by the Optinose device, with matching placebo in subjects with bilateral nasal polyposis and nasal congestion.
What is the current status of trial NCT01624662?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 323 participants. The study started on 2013-10-30. Estimated completion is 2015-07-03.
What conditions does trial NCT01624662 study?
This clinical trial studies the following conditions: Bilateral Nasal Polyposis.
What interventions are being tested in trial NCT01624662?
The interventions under investigation include: Fluticasone propionate (DRUG).
Who is sponsoring clinical trial NCT01624662?
This trial is sponsored by Optinose US, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01624662 being conducted?
This trial has 10 study locations across California, Colorado, Kentucky, Maryland, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bilateral Nasal Polyposis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.